The nominating committee has been constituted in accordance with the resolution adopted by the annual general meeting (“AGM”) 2023.

The AGM 2023 resolved that a nominating committee should be appointed in accordance with the following: “The nominating committee shall consist of representatives for the three largest shareholders in terms of votes as of 30 September each year. If any of these shareholders refrains from appointing a representative, the following shareholders shall, in the order of magnitude, be given the opportunity to appoint a representative until three members have been appointed. The names of the members in the nominating committee must be published by the company no later than six months prior to the coming AGM. The shareholder representative who represents the largest shareholder, shall be appointed chairman of the nominating committee, unless the nominating committee decides otherwise”.

The nominating committee has been constituted in accordance with the resolution adopted by the AGM 2023. The nominating committee consists of Kjetil Myrlid Aasen, Ivar Nordqvist and Marcus Isaksson representing Thoren Tillväxt AB.

The nominating committee’s tasks include submitting proposals to the AGM regarding:
• Chairman of the AGM
• Election of board members
• Chairman of the board of directors
• Remuneration to the board of directors including the chairman
• Election of auditor and remuneration to the auditor
• Rules of procedure for the nominating committee.
 
Shareholders may submit proposals to the Nominating Committee no later than eight weeks prior to the 2024 Annual General Meeting. Proposals can be sent by e-mail to shareholders@combigene.com or letter to CombiGene AB, Attn: Nominating Committee, Agavägen 52A, SE-181 55 Lidingö, Sweden.